Results 201 to 210 of about 270,238 (257)

Intraoperative balloon angioplasty

European Journal of Vascular Surgery, 1989
Since 1981 intraoperative balloon dilatation has been performed in 78 patient suffering from occlusive arterial disease of the lower extremities. The indications were claudication in 32, and limb salvage in 46 patients. In most of the 34 patients in whom a proximal iliac stenosis was dilated in association with a femoro-popliteal bypass (10 patients ...
G, Weber, T, Kiss
openaire   +2 more sources

Microwave Balloon Angioplasty

Electro International, 1991, 1991
Experimental studies have led to the conclusion that microwave balloon angioplasty (MBA) is effective in enhancing the primary result of angioplasty. The feasibility and efficacy of a microwave system to enhance the result of the primary angioplasty procedure were demonstrated for normal and atherosclerotic rabbit models.
P. Walinsky, A. Rosen, D. Smith, D. Nardone, A. Martinez-Hernandez, Z. Kosman   +5 more
openaire   +1 more source

Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial.

Radiology, 2020
Background Paclitaxel drug-coated balloon (DCB) catheter angioplasty is the preferred treatment for revascularization of femoropopliteal lesions in peripheral artery disease, but mortality is a safety concern. Purpose To assess 2-year efficacy and safety
U. Teichgräber, T. Lehmann, R. Aschenbach, D. Scheinert, T. Zeller, K. Brechtel, E. Blessing, M. Lichtenberg, P. von Flotow, B. Heilmeier, S. Sixt, S. Brucks, C. Erbel, U. Beschorner, M. Werk, V. Riambau, A. Wienke, C. Klumb, M. Thieme   +18 more
semanticscholar   +1 more source

Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis: The BASIS Randomized Clinical Trial.

Journal of the American Medical Association (JAMA)
Importance Previous randomized clinical trials did not demonstrate the superiority of endovascular stenting over aggressive medical management for patients with symptomatic intracranial atherosclerotic stenosis (sICAS).
Xuan Sun, Yiming Deng, Yong Zhang, Ming Yang, D. Sun, Thanh N. Nguyen, X. Tong, G. Peng, Aihua Liu, Yun Xu, Yunhu Wu, Xiaokun Geng, Yang Wang, Tianxiao Li, S. Xing, Wei Wu, Yunxiang Ji, Hua Yang, Shouchun Wang, Xiaoping Gao, Weimin Yang, Xing-fu Zhao, Liping Liu, N. Ma, F. Gao, D. Mo, X. Huo, Ligang Song, Xiaoqing Li, Jingbo Zhang, Hongwei He, Ming Lv, S. Mu, Wengui Yu, David S. Liebeskind, Sepideh Amin-Hanjani, Yongjun Wang, Yilong Wang, Zhongrong Miao   +38 more
semanticscholar   +1 more source

Drug‐coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta‐analysis of randomized controlled trials

Catheterization and cardiovascular interventions, 2019
Drug‐coated balloon (DCB) angioplasty has emerged as a mainstay of therapy for the treatment of peripheral arterial disease (PAD) involving the superficial femoral and popliteal arteries.
Mahesh Anantha-Narayanan, Samit M. Shah, Qurat-ul-ain Jelani, S. Garcia, C. Ionescu, C. Regan, Carlos I Mena-Hurtado   +6 more
semanticscholar   +1 more source

Hemodialysis Arteriovenous Fistula and Graft Stenoses: Randomized Trial Comparing Drug-eluting Balloon Angioplasty with Conventional Angioplasty.

Radiology, 2018
Purpose To compare lesion primary patency and restenosis rates between drug-eluting balloon (DEB) percutaneous transluminal angioplasty (PTA) and conventional balloon PTA (cPTA) in the treatment of arteriovenous fistula (AVF) and arteriovenous graft (AVG)
F. Irani, T. Teo, K. Tay, W. Yin, H. Win, A. Gogna, Ankur Patel, C. W. Too, S. Chan, R. Lo, L. Toh, S. Chng, H. Choong, B. Tan   +13 more
semanticscholar   +1 more source

Comparison of drug-coated balloon angioplasty versus conventional angioplasty for arteriovenous fistula stenosis: Systematic review and meta-analysis

Journal of Vascular Access, 2019
Background: Arteriovenous fistula is the most preferred form of vascular access, but stenosis treated by balloon angioplasty is prone to restenosis. Multiple trials have been published with regard to the use of paclitaxel-coated balloon to prolong lesion
Sohail Abdul Salim, H. Tran, C. Thongprayoon, T. Fülöp, W. Cheungpasitporn   +4 more
semanticscholar   +1 more source

Peripheral angioplasty balloon technology

Cardiovascular and Interventional Radiology, 1993
Changes in balloon and catheter technology have led to the development of smaller, more flexible, and less traumatic balloon dilatation systems. The physical principles that govern balloon angioplasty and the current status of balloon materials and catheter designs will be reviewed. A compilation of various angioplasty catheters is also summarized.
A H, Matsumoto, K H, Barth, J B, Selby, C J, Tegtmeyer   +3 more
openaire   +2 more sources

The predictors of complications in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

Catheterization and cardiovascular interventions, 2019
The aims of this study were to (1) evaluate risk factors of complications of balloon pulmonary angioplasty (BPA) and (2) assess the mechanism of the complications.
N. Ikeda, S. Kubota, T. Okazaki, R. Iijima, Hidehiko Hara, Y. Hiroi, Masato Nakamura   +6 more
semanticscholar   +1 more source

Balloon angioplasty by vascular surgeons

The American Journal of Surgery, 1997
Endovascular treatment of arterial disease of the lower extremity is performed by radiologists, cardiologists, and some vascular surgeons. This retrospective review was performed to measure complications and success rates in patients with extensive occlusive disease treated by vascular surgeons.Balloon angioplasties were performed on 336 vascular ...
F A, Madera, P M, Orecchia, R A, Razzino, J, Razzino, D, Calcagno   +4 more
openaire   +2 more sources